Robert C. Goldstein, MD, chief medical officer of Somnia Anesthesia, said in a blog post in response to the New York Times article that he supports the use of Propofol for colonoscopy. “Although using a general anesthetic administered by an anesthesiologist or nurse anesthetist may mean an added cost to the patient or insurance company for a colonoscopy, the health and financial benefits far outweigh the costs,” he said.
“In multiple studies conducted over the past few years, results have shown that use of a more potent drug, such as Propofol, for inducing anesthesia improves the polyp detection rates and cancer diagnosis rates, sometimes by as much as 43 percent. These early detections not only save lives, but often spare patients and insurance companies the long and costly process of cancer treatment,” said Dr. Goldstein.
More Articles on Somnia Anesthesia
Avoiding a Hurricane: How to Evaluate Your Anesthesia Provider and Ensure Your OR’s Success
Podcast Interview With Somnia Anesthesia’s Dr. Marc Koch: Evaluating Anesthesia Services
Evaluating Your Anesthesia Services — How to Assess Your Anesthesia Team
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
